Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene
HALL, Chad A, RUNSHENG WANG, JIANGYONG MIAO, OLIVA, Esther, XIAOYUN SHEN, WHEELER, Thomas, HILSENBECK, Susan G, ORSULIC, Sandra, GOODE, Scott
Published in Cancer research (Chicago, Ill.) (01.11.2010)
Published in Cancer research (Chicago, Ill.) (01.11.2010)
Get full text
Journal Article
Shortening the biologics clinical timeline with a novel method for generating stable, high-producing cell pools and clones
Hall, Chad A, Kravitz, Rachel H, Johnson, Karl F, Sanek, Nicholas A, Maiti, Payel, Ziemba, Keith R, Liu, Jia, Andreev, Dmitri O, Chrostowski, Victoria L, Collins, Ian J, Bleck, Gregory T
Published in Biotechnology and bioengineering (12.01.2023)
Published in Biotechnology and bioengineering (12.01.2023)
Get full text
Journal Article
Extracellular Antibody Drug Conjugates Exploiting the Proximity of Two Proteins
Marshall, David J, Harried, Scott S, Murphy, John L, Hall, Chad A, Shekhani, Mohammed S, Pain, Christophe, Lyons, Conner A, Chillemi, Antonella, Malavasi, Fabio, Pearce, Homer L, Thorson, Jon S, Prudent, James R
Published in Molecular therapy (01.10.2016)
Published in Molecular therapy (01.10.2016)
Get full text
Journal Article
Disruption of the eIF4F translation initiation complex as a determinant of diffuse large B-cell lymphoma responsiveness to enzastaurin (LY317615.HCl) and its primary metabolite (LY326020)
Graff, Jeremy Richard, McNulty, Ann M, Dumstorf, Chad A, Parsons, Stephen H, Konicek, Bruce W, Hall, Chad A
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Abstract LB-235: Sensitivity of diffuse large B cell lymphoma cells to Enzastaurin (LY317615.HCl) and its primary metabolite (LY326020) is critically dependent upon disruption of the eIF4F translation initiation complex
McNulty, Ann M., Dumstorf, Chad A., Parsons, Stephen H., Konicek, Bruce W., Hall, Chad A., Graff, Jeremy R.
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article